BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Lakeland Industries
LAKE
$113M
| $3.6M | ﹤0.01% |
161,073
-421,200
| -72% | -$10.9M |
|
|
ASAI
3902
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $3.59M | ﹤0.01% |
209,685
-3,290
| -2% | -$51.8K |
|
|
MSB
3903
Mesabi Trust
MSB
$289M
| $3.57M | ﹤0.01% |
100,856
+27,506
| +37% | +$994K |
|
3904
Priority Technology Holdings
PRTH
$535M
| $3.57M | ﹤0.01% |
467,084
+85,790
| +22% | +$617K |
|
3905
Brookfield
BN
$104B
| $3.56M | ﹤0.01% |
129,699
+8,785
| +7% | +$225K |
|
|
CLVR
3906
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $3.55M | ﹤0.01% |
11,658
+1,035
| +10% | +$319K |
|
|
FTH
3907
Faeth Therapeutics
FTH
$702M
| $3.55M | ﹤0.01% |
18,173
+1,538
| +9% | +$380K |
|
|
TTOO
3908
DELISTED
T2 Biosystems, Inc
TTOO
| $3.54M | ﹤0.01% |
594
-7
| -1% | -$45.2K |
|
3909
Universal Technical Institute
UTI
$2.16B
| $3.53M | ﹤0.01% |
544,494
-1,542,441
| -74% | -$9.11M |
|
|
IMPX
3910
DELISTED
AEA-Bridges Impact Corp
IMPX
| $3.51M | ﹤0.01% |
360,431
-443,567
| -55% | -$4.35M |
|
3911
iShares Core 10+ Year USD Bond ETF
ILTB
$592M
| $3.51M | ﹤0.01% |
48,526
+11,412
| +31% | +$801K |
|
|
JPXN
3912
iShares JPX-Nikkei 400 ETF
JPXN
$134M
| $3.5M | ﹤0.01% |
48,624
+620
| +1% | +$45.3K |
|
|
LTCHW
3913
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
| $3.5M | ﹤0.01% |
+1,000,000
| New | +$2.58M |
|
3914
Alico
ALCO
$280M
| $3.49M | ﹤0.01% |
97,966
-269,150
| -73% | -$8.51M |
|
3915
ADMA Biologics
ADMA
$1.96B
| $3.48M | ﹤0.01% |
2,178,232
-3,575,588
| -62% | -$6.29M |
|
3916
NLI Holdings
NL
$281M
| $3.48M | ﹤0.01% |
535,999
-49,792
| -8% | -$368K |
|
3917
Orion Group Holdings
ORN
$396M
| $3.46M | ﹤0.01% |
601,945
-87,941
| -13% | -$512K |
|
3918
Urban One Class D
UONEK
$22.8M
| $3.45M | ﹤0.01% |
68,820
-8,587
| -11% | -$301K |
|
3919
STRATTEC Security
STRT
$367M
| $3.45M | ﹤0.01% |
77,582
-15,028
| -16% | -$719K |
|
|
AIOT
3920
PowerFleet Inc
AIOT
$526M
| $3.43M | ﹤0.01% |
476,841
-1,640,416
| -77% | -$12M |
|
3921
AMES National
ATLO
$271M
| $3.43M | ﹤0.01% |
139,984
-523,082
| -79% | -$13.2M |
|
|
KL
3922
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $3.41M | ﹤0.01% |
88,541
-11,368
| -11% | -$456K |
|
|
CEREW
3923
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
| $3.41M | ﹤0.01% |
236,914
| – | – |
|
|
LABP
3924
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $3.4M | ﹤0.01% |
29,404
+3,775
| +15% | +$421K |
|
|
MOLN
3925
Molecular Partners
MOLN
$147M
| $3.38M | ﹤0.01% |
+165,038
| New | +$3.27M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.